Publications:144
- Home
- Profiles
M. Cecilia Berin, PhD
- About Me
- Education & Certifications
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Education
BSc(Hons), Queen's University
MSc, Queen's University
PhD, McMaster University
Postdoctoral, University of California, San Diego
Publications
Selected Publications
- Contribution of T cell subsets to different food allergic diseases. Lisa Hung, Brianna Zientara, M. Cecilia Berin. Immunological Reviews
- Joint transcriptomic and cytometric study of children with peanut allergy reveals molecular and cellular cross talk in reaction thresholds. Lingdi Zhang, Yoojin Chun, Zoe Arditi, Galina Grishina, Tracy Lo, Kayla Wisotzkey, Charuta Agashe, Alexander Grishin, Julie Wang, Hugh A. Sampson, Scott Sicherer, M. Cecilia Berin, Supinda Bunyavanich. Journal of Allergy and Clinical Immunology
- Coculture of Human Dendritic and T Cells for the Study of Specific T Cell-Mediated Responses Against Food Allergens. Mónica Martínez-Blanco, David Menchén-Martínez, Carmen Cámara, Rosina López-Fandiño, M. Cecilia Berin, Daniel Lozano-Ojalvo.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Berin has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Berin has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.